Medtronic Voluntarily Suspends Distribution Of Sprint Fidelis® Defibrillation Leads
Medtronic, Inc. (NYSE:MDT) said recently that it has voluntarily suspended worldwide distribution of the Sprint Fidelis® family of defibrillation leads because of the potential for lead fractures. In addition, the company recommends against new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949). [click link for full article]
More: continued here
Filed under: Cardiovascular on October 20th, 2007